Amedisys, Inc. (AMED) Thwomps Q2 Profit Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Amedisys Reports Second Quarter Financial Results
July 30, 2014 7:00 AM EDTBATON ROUGE, La., July 30, 2014 (GLOBE NEWSWIRE) -- Amedisys, Inc. (Nasdaq: AMED), a leading home health and hospice company, today reported its financial results for the three and six-month periods ended June 30, 2014.
Three-Month Periods Ended June 30, 2014 and 2013
After adding back for the 2014 period, $0.8 million ($0.5 million, net of income tax ) or $0.02 per diluted share and for the 2013 period $6.1 million ($3.8 million, net of income tax) or $0.12 per diluted share for certain items*, our adjusted results from continuing operations were as follows: Net service revenue of $305.0 million compared to $316.0 million in 2013. Net income from... More